M. Bergström

发表

Developments in PET for the detection of endocrine tumours.

M. Bergström, B. Långström, A. Sundin, 2005, Best practice & research. Clinical endocrinology & metabolism.

Use of PET in neuroendocrine tumors. In vivo applications and in vitro studies.

M. Bergström, B. Långström, A. Sundin, 2000, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Methodological aspects for in vitro characterization of receptor binding using 11C-labeled receptor ligands: a detailed study with the benzodiazepine receptor antagonist [11C]Ro 15-1788.

H. Onoe, M. Bergström, B. Långström, 1997, Nuclear medicine and biology.

PET with 11C‐deuterium‐deprenyl and 18F‐FDG in focal epilepsy

B. Långström, M. Bergström, B. Långström, 2001, Acta neurologica Scandinavica.

Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography.

A Sundin, M. Bergström, B. Långström, 2000, Nuclear medicine and biology.

Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine.

T Greitz, H von Holst, V P Collins, 1983, Journal of computer assisted tomography.

Triazolam-induced modulation of muscarinic acetylcholine receptor in living brain slices as revealed by a new positron-based imaging technique

H. Onoe, Y. Yonekura, M. Bergström, 1998, Journal of Neural Transmission.

In vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11-DOPA to carbon-11-dopamine.

M. Bergström, B. Långström, A. Sundin, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography

M. Bergström, B. Långström, A. Sundin, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Positron emission tomography (PET) with 11C-5-hydroxytryptophan (5-HTP) in patients with metastatic hormone-refractory prostatic adenocarcinoma.

M. Bergström, G. Antoni, B. Långström, 1997, Nuclear medicine and biology.

Delineation of Gliomas with Magnetic Resonance Imaging Using Gd-DTPA in Comparison with Computed Tomography and Positron Emission Tomography

M. Bergström, K. Bergström, M. Tovi, 1990, Acta radiologica.

In vitro and in vivo characterization of (+)-3-[11C]cyano-dizocilpine

H. Onoe, M. Bergström, B. Långström, 1998, Journal of Neural Transmission.

PET as a tool in the clinical evaluation of pituitary adenomas.

M. Bergström, B. Långström, P. Lundberg, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11C]Hyaluronan uptake with positron emission tomography in liver disease

Långström, Sundin, Bergström, 2000, European journal of clinical investigation.

Synthesis of some 11C-labelled MAO-A inhibitors and their in vivo uptake kinetics in rhesus monkey brain.

M. Bergström, B. Långström, G. Westerberg, 1997, Nuclear medicine and biology.

11C-harmine as a tracer for monoamine oxidase A (MAO-A): in vitro and in vivo studies.

M. Bergström, B. Långström, G. Westerberg, 1997, Nuclear medicine and biology.

PET-methionine of skull base neuromas and meningiomas.

M. Bergström, B. Långström, P. Enblad, 1997, Acta oto-laryngologica.